International travel If you are traveling internationally, research the customs regulations for your destination regarding injectable medications
In a regulatory filing, the company acknowledged the uncertain future of its compounded GLP-1 offerings: While it believes there are paths to continue offering access to certain compounded GLP-1s after the shortage ends, it cannot guarantee that we will be able to continue offering these products in the same manner, to the same extent, or at all." The FDA's Friday announcement removed Wegovy from its shortage list, giving compounding pharmacies a 60-90 day window to discontinue production of copies of Novo Nordisk's patented medication
Topamax is not approved for weight loss, but some doctors prescribe it off-label for individuals who are obese or have weight-related health concerns
These hormones stimulate insulin secretion while inhibiting glucagon release, leading to a reduction in blood sugar levels
inexpensive per bottle
Proven track record: The injectable form has been the primary standard for significant weight loss results in clinical settings